ArticleCureus2026
Beyond BRUE (Brief Resolved Unexplained Event): Recurrent Unexplained Events Revealing Congenital Hyperinsulinism in Infancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brief resolved unexplained events (BRUEs) are uncommon yet clinically significant presentations in infancy that require careful risk stratification, as recurrent episodes may herald serious occult pathology. We report a four-month-old term female infant with a notable family history of sudden unexplained sibling deaths who was admitted to and later discharged from our institution twice for recurrent BRUE episodes following an initially unrevealing workup. She subsequently presented again with vomiting, diarrhea, dehydration, metabolic acidosis, and persistent hypoglycemia, necessitating admission to the pediatric intensive care unit (PICU). During PICU admission, the infant developed recurrent hypoglycemia despite escalating intravenous glucose infusion rates (GIRs). Critical sampling demonstrated inappropriately detectable insulin and C-peptide, absent ketonuria, suppressed β-hydroxybutyrate, and a diagnostically significant glycemic response to glucagon, confirming hyperinsulinemic hypoglycemia (HH) consistent with congenital hyperinsulinism (CHI). She responded promptly to diazoxide and hydrochlorothiazide, allowing successful weaning from intravenous glucose and transition to full oral feeds. This case compellingly demonstrates how seemingly benign recurrent BRUE episodes may, in fact, constitute the earliest clinical clue to a serious yet treatable occult disorder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.